OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q2 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $688,000 | +67.4% | 173,200 | +67.7% | 0.01% | +80.0% |
| Q4 2018 | $411,000 | -42.2% | 103,300 | 0.0% | 0.01% | -28.6% |
| Q3 2018 | $711,000 | +2.0% | 103,300 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $697,000 | +3.7% | 103,300 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $672,000 | +46.1% | 103,300 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $460,000 | -27.9% | 103,300 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $638,000 | -31.2% | 103,300 | +3.3% | 0.01% | -36.4% |
| Q2 2017 | $927,000 | -0.1% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $928,000 | +10.9% | 100,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $837,000 | +21.8% | 100,000 | 0.0% | 0.01% | +10.0% |
| Q3 2016 | $687,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |